In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study-Reference-Cited by-同舟云学术

In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study

Published:2009-05-16 Issue:11 Volume:135 Page:1513-1520
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kim Hee Seung,Kim Tae Joong,Chung Hyun Hoon,Kim Jae Weon,Kim Byung Gie,Park Noh Hyun,Song Yong Sang,Bae Duk Soo,Kang Soon Beom

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-009-0598-0.pdf

Reference33 articles.

1. Albrecht M, Simon WE, Hölzel F (1985) Individual chemosensitivity of in vitro proliferating mammary and ovarian carcinoma cells in comparison to clinical results of chemotherapy. J Cancer Res Clin Oncol 109:210–216. doi: 10.1007/BF00390360

2. Berek JS (1992) Second-look versus second-nature. Gynecol Oncol 44:1–2. doi: 10.1016/0090-8258(92)90001-Y

3. Chen Y, He M, Wu Y, Li H, Yu D (2001) Investigation on marking method for phenomenon on regrowth drug resistance in relapsed acute myelogenous leukemia. J Tongji Med Univ 21:286–288

4. Cortazar P, Johnson BE (1999) Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 17:1625–1631

5. d’Amato TA, Landreneau RJ, McKenna RJ, Santos RS, Parker RJ (2006) Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer. Ann Thorac Surg 81:440–446 (discussion 6–7)

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gynecologic and Breast Cancers: What's New in Chemoresistance and Chemosensitivity Tests?;Current Problems in Cancer;2023-08

2. A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases;Translational Oncology;2019-07

3. Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer;International Journal of Gynecologic Cancer;2019-01-04

4. THE INHIBITIVE EFFECTS OF ORIDONIN ON CISPLATIN-RESISTANT OVARIAN CANCER CELLS VIA INDUCING CELL APOPTOSIS AND INHIBITING ADAM17;ACTA MEDICA MEDITERR;2018

5. Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test);Journal of Ovarian Research;2017-10-27